S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
My biggest AI fear (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
My biggest AI fear (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
My biggest AI fear (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
My biggest AI fear (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free CRL Stock Alerts
$226.78
-0.77 (-0.34%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 9
Before Market Opens
Confirmed
Actual EPS
(Feb. 14)
$2.46 Beat By $0.07
Consensus EPS
(Feb. 14)
$2.39
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CRL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Charles River Laboratories International Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$2.05$2.73$2.39 
Q2 20242$2.63$2.68$2.66 
Q3 20242$3.02$3.09$3.06 
Q4 20242$3.19$3.37$3.28 
FY 20248$10.89$11.87$11.38 
Q1 20251$2.92$2.92$2.92 
Q2 20251$2.98$2.98$2.98 
Q3 20251$3.11$3.11$3.11 
Q4 20251$3.32$3.32$3.32 
FY 20254$12.33$12.33 $12.33

CRL Earnings Date and Information

Charles River Laboratories International last issued its earnings results on February 14th, 2024. The medical research company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.39 by $0.07. The firm earned $1.01 billion during the quarter, compared to analysts' expectations of $991.25 million. Its revenue for the quarter was down 7.9% compared to the same quarter last year. Charles River Laboratories International has generated $9.21 earnings per share over the last year ($9.21 diluted earnings per share) and currently has a price-to-earnings ratio of 24.6. Earnings for Charles River Laboratories International are expected to grow by 12.35% in the coming year, from $11.01 to $12.37 per share. Charles River Laboratories International has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Charles River Laboratories International will be holding an earnings conference call on Thursday, May 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Charles River Laboratories International Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Confirmed)		-------  
2/14/2024Q4 2023$2.39$2.46+$0.07$1.30$991.25 million$1.01 billion      
11/8/2023Q3 2023$2.35$2.72+$0.37$3.75$1.00 billion$1.03 billion      
8/9/2023Q2 2023$2.63$2.69+$0.06$3.49$1.05 billion$1.06 billion      
5/11/2023Q1 2023$2.59$2.78+$0.19$3.55$988.10 million$1.03 billion
2/22/2023Q4 2022$2.75$2.98+$0.23$2.31$1.04 billion$1.10 billion      
11/2/2022Q3 2022$2.51$2.63+$0.12$3.38$978.65 million$989.16 million
8/3/2022Q2 2022$2.74$2.77+$0.03$3.41$995.12 million$973.13 million    
5/4/2022Q1 2022$2.71$2.75+$0.04$3.69$908.64 million$913.93 million      
2/16/2022Q4 2021$2.42$2.49+$0.07$2.31$888.27 million$905.05 million    
11/2/2021Q3 2021$2.58$2.70+$0.12$3.39$902.03 million$895.90 million    
8/3/2021Q2 2021$2.38$2.61+$0.23$3.50$880.72 million$914.61 million    
5/3/2021Q1 2021$2.19$2.53+$0.34$3.86$798.52 million$824.60 million  

Charles River Laboratories International Earnings - Frequently Asked Questions

When is Charles River Laboratories International's earnings date?

Charles River Laboratories International has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on CRL's earnings history.

Did Charles River Laboratories International beat their earnings estimates last quarter?

In the previous quarter, Charles River Laboratories International (NYSE:CRL) reported $2.46 earnings per share (EPS) to beat the analysts' consensus estimate of $2.39 by $0.07. Learn more on analysts' earnings estimate vs. CRL's actual earnings.

How can I listen to Charles River Laboratories International's earnings conference call?

The conference call for Charles River Laboratories International's latest earnings report can be listened to online. Listen to Conference Call

How can I read Charles River Laboratories International's conference call transcript?

The conference call transcript for Charles River Laboratories International's latest earnings report can be read online. Read Transcript

How can I view Charles River Laboratories International's earnings report?

Charles River Laboratories International's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Charles River Laboratories International generate each year?

Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.13 billion.

How much profit does Charles River Laboratories International generate each year?

Charles River Laboratories International (NYSE:CRL) has a recorded net income of $474.62 million. CRL has generated $9.21 earnings per share over the last four quarters.

What is Charles River Laboratories International's price-to-earnings ratio?

Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 24.62 and a forward price-to-earnings ratio of 20.60. The price/earnings-to-growth ratio is 1.8.

What is Charles River Laboratories International's EPS forecast for next year?

Charles River Laboratories International's earnings are expected to grow from $11.01 per share to $12.37 per share in the next year, which is a 12.35% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:CRL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press
The #1 Crypto for 2024
InvestorPlace